Adverse Drug Reactions in the Exotic Animal Patient

Area of Science:

• Veterinary Toxicology
• Exotic Animal Medicine
• Wildlife Health

Background:

• Veterinary pharmaceuticals are essential for treating exotic and wildlife species.
• Adverse drug reactions can be severe and species-specific in these populations.
• Limited data exists on the toxicologic profiles of many drugs in non-traditional species.

Purpose of the Study:

• To summarize major veterinary drugs and their associated toxicologic risks in exotic and wildlife animals.
• To highlight species-specific sensitivities and potential adverse effects.
• To emphasize the importance of tailored drug selection and administration.

Main Methods:

• Literature review of veterinary drugs and their toxicologic effects.
• Analysis of adverse events reported in exotic and wildlife species.
• Compilation of data on drug sensitivities across various animal groups.

Main Results:

• Common drug classes (antibiotics, sedatives, anesthetics, analgesics, antiparasitics, THC) can cause significant adverse effects.
• Exotic species like small mammals, reptiles, birds, and amphibians exhibit heightened sensitivity to specific agents (e.g., beta-lactams, acetaminophen, ivermectin).
• Adverse effects include dysbiosis, organ toxicity (nephrotoxicity, hepatotoxicity), neurotoxicity, and cardiopulmonary compromise.

Conclusions:

• Veterinary drug use in exotic and wildlife species requires careful consideration of species-specific toxicities.
• Dose, route of administration, and individual patient factors significantly influence drug safety.
• Emphasizing species-specific knowledge and supportive care is paramount for mitigating risks and ensuring positive outcomes.